Tempus AI

Tempus AI R&D per Employee

The R&D Spending per Employee of Tempus AI (TEM) as of Nov 20, 2026 is 83,955.53 USD. In the previous year, R&D Spending per Employee was 83,380.00 USD — a change of 0.69% (higher).

R&D per Employee

83,955.53USD

YoY

0.69%

Last updated:

R&D Spending per Employee of Tempus AI is 2025 83,955.53 USD. R&D Spending per Employee of Tempus AI was 2024 83,380.00 USD. It decreases by 0.69% higher compared to the previous year.

The Tempus AI R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2019
14,963.42 USD
Jan 1, 2020
24,020.00 USD
Jan 1, 2021
33,776.58 USD
Jan 1, 2022
42,697.63 USD
Jan 1, 2023
48,815.26 USD
Jan 1, 2024
83,380.00 USD
Jan 1, 2025
83,955.53 USD
The Tempus AI R&D per Employee history
YEARR&D per EmployeeYoY
83,955.53USD+0.69%
83,380.00USD+70.81%
48,815.26USD+14.33%
42,697.63USD+26.41%
33,776.58USD+40.62%
24,020.00USD+60.52%
14,963.42USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tempus AI Stock analysis

What does Tempus AI do? Tempus AI Inc provides next generation diagnostics through genomics, data, and AI applications. Its genomics product line includes next generation sequencing, diagnostics, PCR, profiling, molecular genotyping, and pathology testing. The AI applications focus on algorithmic diagnostics, software as a medical device, and clinical decision support tools. The primary AI product Next uses machine learning to identify care gaps for oncology and cardiology patients. The company serves healthcare providers and life sciences organizations seeking personalized medicine solutions. Tempus AI Inc's revenue comes from its genomics and AI product lines. The genomics services are delivered through its laboratories, offering sequencing, diagnostics, and molecular testing. The AI applications, particularly Next, are sold as software solutions to healthcare institutions. The target customers are healthcare providers and life sciences companies that require advanced diagnostic tools for personalized treatment plans. The company operates in the Life Sciences Tools & Services industry, focusing on oncology and cardiology segments. The company's genomics product line generates revenue through laboratory services for molecular pathology testing. AI applications like Next are sold as medical device software, targeting healthcare institutions for clinical decision support. The primary segments served are oncology and cardiology, where personalized medicine is critical. The company's products are designed to integrate with existing healthcare data systems to improve patient care outcomes. Tempus AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tempus AI stock

R&D Spending per Employee of Tempus AI is 83,955.53 USD in 2025.

R&D Spending per Employee of Tempus AI changed from 83,380.00 USD to 83,955.53 USD, representing a 0.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Tempus AI since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Tempus AI historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Tempus AI

All Key Metrics — Tempus AI